Preliminary phase II results presented for pazopanib/paclitaxel combination in urothelial carcinoma Feb. 14, 2014
Cabozantinib shows clinical activity in phase II trials in patients with urothelial carcinoma Feb. 13, 2014
Phase III trial of orteronel plus prednisone in patients with mCRPC does not meet primary endpoint Feb. 12, 2014
Results from preliminary safety study evaluating trebananib plus abiraterone in patients with CRPC Feb. 11, 2014
RSS